Shang-Ying Hu1,2, Aimée R Kreimer2, Carolina Porras3, Diego Guillén3, Mario Alfaro3, Teresa M Darragh4, Mark H Stoler5, Luis F Villegas3, Rebecca Ocampo3, Ana Cecilia Rodriguez6, Mark Schiffman2, Sabrina H Tsang2, Douglas R Lowy2,7, John T Schiller7, John Schussler8, Wim Quint9, Mitchell H Gail2, Joshua N Sampson2, Allan Hildesheim2, Rolando Herrero3,10. 1. Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. 3. Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación INCIENSA, San José, Costa Rica. 4. School of Medicine, University of California, San Francisco, CA, USA. 5. Department of Pathology, University of Virginia, Charlottesville, VA, USA. 6. Independent Consultant, San José, Costa Rica. 7. Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Rockville, MD, USA. 8. Information Management Services, Silver Spring, MD, USA. 9. Viroclinics-DDL, Rijswijk, Netherlands. 10. Early Detection Prevention and Infections, International Agency for Research on Cancer, Lyon, France.
Abstract
BACKGROUND: We investigated the impact of human papillomavirus (HPV) vaccination on the performance of cytology-based and HPV-based screening for detection of cervical precancer among women vaccinated as young adults and reaching screening age. METHODS: A total of 4632 women aged 25-36 years from the Costa Rica HPV Vaccine Trial were included (2418 HPV-vaccinated as young adults and 2214 unvaccinated). We assessed the performance of cytology- and HPV-based cervical screening modalities in vaccinated and unvaccinated women to detect high-grade cervical precancers diagnosed over 4 years and the absolute risk of cumulative cervical precancers by screening results at entry. RESULTS: We detected 95 cervical intraepithelial neoplasia grade 3 or worse (52 in unvaccinated and 43 in vaccinated women). HPV16/18/31/33/45 was predominant (69%) among unvaccinated participants, and HPV35/52/58/39/51/56/59/66/68 predominated (65%) among vaccinated participants. Sensitivity and specificity of cervical screening approaches were comparable between women vaccinated as young adults and unvaccinated women. Colposcopy referral rates were lower in the vaccinated group for HPV-based screening modalities, but the positive predictive value was comparable between the 2 groups. CONCLUSIONS: Among women approaching screening ages, vaccinated as young adults, and with a history of intensive screening, the expected reduction in the positive predictive value of HPV testing, associated with dropping prevalence of HPV-associated lesions, was not observed. This is likely due to the presence of high-grade lesions associated with nonvaccine HPV types, which may be less likely to progress to cancer. Published by Oxford University Press 2022.
BACKGROUND: We investigated the impact of human papillomavirus (HPV) vaccination on the performance of cytology-based and HPV-based screening for detection of cervical precancer among women vaccinated as young adults and reaching screening age. METHODS: A total of 4632 women aged 25-36 years from the Costa Rica HPV Vaccine Trial were included (2418 HPV-vaccinated as young adults and 2214 unvaccinated). We assessed the performance of cytology- and HPV-based cervical screening modalities in vaccinated and unvaccinated women to detect high-grade cervical precancers diagnosed over 4 years and the absolute risk of cumulative cervical precancers by screening results at entry. RESULTS: We detected 95 cervical intraepithelial neoplasia grade 3 or worse (52 in unvaccinated and 43 in vaccinated women). HPV16/18/31/33/45 was predominant (69%) among unvaccinated participants, and HPV35/52/58/39/51/56/59/66/68 predominated (65%) among vaccinated participants. Sensitivity and specificity of cervical screening approaches were comparable between women vaccinated as young adults and unvaccinated women. Colposcopy referral rates were lower in the vaccinated group for HPV-based screening modalities, but the positive predictive value was comparable between the 2 groups. CONCLUSIONS: Among women approaching screening ages, vaccinated as young adults, and with a history of intensive screening, the expected reduction in the positive predictive value of HPV testing, associated with dropping prevalence of HPV-associated lesions, was not observed. This is likely due to the presence of high-grade lesions associated with nonvaccine HPV types, which may be less likely to progress to cancer. Published by Oxford University Press 2022.
Authors: Megan A Clarke; Patricia Luhn; Julia C Gage; Clara Bodelon; S Terence Dunn; Joan Walker; Rosemary Zuna; Stephen Hewitt; J Keith Killian; Liying Yan; Andrew Miller; Mark Schiffman; Nicolas Wentzensen Journal: Int J Cancer Date: 2017-05-26 Impact factor: 7.396
Authors: Philip E Castle; Xianhong Xie; Xiaonan Xue; Nancy E Poitras; Thomas S Lorey; Walter K Kinney; Nicolas Wentzensen; Howard D Strickler; Emily A Burger; Mark Schiffman Journal: Prev Med Date: 2018-10-11 Impact factor: 4.018
Authors: Rolando Herrero; Sholom Wacholder; Ana C Rodríguez; Diane Solomon; Paula González; Aimee R Kreimer; Carolina Porras; John Schussler; Silvia Jiménez; Mark E Sherman; Wim Quint; John T Schiller; Douglas R Lowy; Mark Schiffman; Allan Hildesheim Journal: Cancer Discov Date: 2011-09-09 Impact factor: 39.397
Authors: Sarah Wagner; David Roberson; Joseph Boland; Aimée R Kreimer; Meredith Yeager; Michael Cullen; Lisa Mirabello; S Terence Dunn; Joan Walker; Rosemary Zuna; Carolina Porras; Bernal Cortes; Joshua Sampson; Rolando Herrero; Ana Cecilia Rodriguez; Wim Quint; Leen-Jan Van Doorn; Allan Hildesheim; Mark Schiffman; Nicolas Wentzensen Journal: J Infect Dis Date: 2019-10-08 Impact factor: 5.226
Authors: T J Palmer; M McFadden; K G J Pollock; K Kavanagh; K Cuschieri; M Cruickshank; S Cotton; S Nicoll; C Robertson Journal: Br J Cancer Date: 2016-02-04 Impact factor: 7.640